Urea

Urea

SCHEMBL2807369

NC(=O)N(C1CCCCC1)C1CCCCC1.NC(N)=O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.43
PHGDH O43175 1/20 0.43
HSD11B1 P28845 2/20 0.41
EPHX1 P07099 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
RECQL P46063 1/20 0.39
ADAM17 P78536 1/20 0.39
KMT2A Q03164 1/20 0.39
S1PR1 P21453 4/20 0.38
S1PR3 Q99500 7/20 0.37
TSHR P16473 1/20 0.37
GAA P10253 1/20 0.37
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19458771 0.97 ALOX5 (0.45) ALOX5PHGDHHSD11B1EPHX1KDM4E
SCHEMBL11234464 0.97 ALOX5 (0.45) ALOX5PHGDHHSD11B1EPHX1KDM4E
SCHEMBL2606404 0.97 ALOX5 (0.45) ALOX5PHGDHHSD11B1EPHX1KDM4E
SCHEMBL2754 0.97 ALOX5 (0.45) ALOX5PHGDHHSD11B1EPHX1KDM4E
Hydrochloric Acid SCHEMBL13518199 0.95 ALOX5 (0.43) ALOX5PHGDHHSD11B1EPHX1KDM4E
SCHEMBL2170733 0.95 ALOX5 (0.43) ALOX5PHGDHHSD11B1EPHX1KDM4E
SCHEMBL9547539 0.92 ALOX5 (0.44) ALOX5PHGDHHSD11B1EPHX1KDM4E
Cyclohexylamine SCHEMBL27429394 0.89 ALOX5 (0.39) ALOX5PHGDHHSD11B1EPHX1KDM4E
SCHEMBL2667248 0.87 HSD11B1 (0.40) ALOX5PHGDHHSD11B1EPHX1KDM4E
SCHEMBL2606355 0.85 HSD11B1 (0.39) ALOX5PHGDHHSD11B1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9770442-B2 Self-assembling amphiphilic polymers as anti-cancer agents ALLEXCEL INC. (US) 2017-09-26 US disclosed
EP-2167103-B1 SELF-ASSEMBLING AMPHIPHILIC POLYMERS AS ANTICANCER AGENTS ALLEXCEL INC (US) 2017-03-01 EP disclosed
US-20100239659-A1 SELF-ASSEMBLING AMPHIPHILIC POLYMERS AS ANTI-CANCER AGENTS ALLEXCEL., INC. (US) 2010-09-23 US disclosed
EP-2167103-A1 SELF-ASSEMBLING AMPHIPHILIC POLYMERS AS ANTICANCER AGENTS Allexcel, Inc. (US) 2010-03-31 EP disclosed
WO-2009011702-A1 SELF-ASSEMBLING AMPHIPHILIC POLYMERS AS ANTICANCER AGENTS ALLEXCEL, INC. (US) 2009-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239659-A1 SELF-ASSEMBLING AMPHIPHILIC POLYMERS AS ANTI-CANCER AGENTS CD44, EPCAM, EGFR ALOX5 1709/4885PHGDH 3037/4885HSD11B1 4364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.